EUVIMEDEUVIMED entdecken
Crossref

Government funding of fluorodeoxyglucose positron emission tomography (FDG‐PET) in rare urological cancers: better data, better outcomes

Jennifer Xu iD, Haidar Al Saffar, Jonathan O'Brien, Brian Kelly iD, Nathan Lawrentschuk iD

BJU International · 2024

DOI: 10.1111/bju.16135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, 2024. Verfasst von Jennifer Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Royal Melbourne Hospital, Parkville, Vic., Australia. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Urologic Neoplasms. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Urologic NeoplasmsHumansPositron-Emission TomographyGovernmentRadiopharmaceuticalsPositron Emission Tomography Computed Tomography

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Urology, Royal Melbourne Hospital, Parkville, Vic., Australia.
  • Department of Uro-Oncology, Peter MacCallum Cancer Centre, Parkville, Vic., Australia.

ORCID-Profile: Jennifer Xu, Brian Kelly, Nathan Lawrentschuk

Zitieren

APA

Xu, J., Al Saffar, H., O'Brien, J., Kelly, B., & Lawrentschuk, N. (2024). Government funding of fluorodeoxyglucose positron emission tomography (FDG‐PET) in rare urological cancers: better data, better outcomes. BJU International. https://doi.org/10.1111/bju.16135

Vancouver

Xu J, Al Saffar H, O'Brien J, Kelly B, Lawrentschuk N. Government funding of fluorodeoxyglucose positron emission tomography (FDG‐PET) in rare urological cancers: better data, better outcomes. BJU International. 2024. doi:10.1111/bju.16135

BibTeX
@article{Xu2024,
  author = {Xu, Jennifer and Al Saffar, Haidar and O'Brien, Jonathan and Kelly, Brian and Lawrentschuk, Nathan},
  title = {Government funding of fluorodeoxyglucose positron emission tomography (FDG‐PET) in rare urological cancers: better data, better outcomes},
  journal = {BJU International},
  year = {2024},
  doi = {10.1111/bju.16135}
}
Kostenlos starten →